Carmen Guadalupe Rodríguez González-rekin lankidetzan egindako argitalpenak (6)

2022

  1. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2020

  1. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2019

  1. Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

    Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Adding value through pharmacy validation: A safety and cost perspective

    Journal of Evaluation in Clinical Practice, Vol. 22, Núm. 2, pp. 253-260

  2. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908